BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3822081)

  • 1. Biological activity of Leu-enkephalin containing hydrophobic moieties.
    Rodriguez RE; Reig F; Valencia G; Herrero JF; Garcia Anton J
    Neuropeptides; 1986; 8(4):335-49. PubMed ID: 3822081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of different receptor subtypes for the production of in vitro and in vivo effects in a series of synthetic enkephalin analogues.
    Watanabe J; Kaneto H; Maeda M; Tsuji T; Kawasaki K
    J Pharmacobiodyn; 1985 Nov; 8(11):975-80. PubMed ID: 3005543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid effects of short enkephalin fragments containing the Gly-Phe sequence on contractile responses of guinea pig ileum.
    Radomirov R; Pencheva N; Stoyneva I; Lazova L
    Gen Pharmacol; 1994 Mar; 25(2):303-9. PubMed ID: 8026730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enkephalin-like character and analgesia.
    Rónai AZ; Berzétei IP; Székely JI; Miglécz E; Kurgyis J; Bajusz S
    Eur J Pharmacol; 1981 Jan; 69(3):263-71. PubMed ID: 7215429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of (D)Ala2,Leu5-enkephalins containing hydrophilic or hydrophobic moieties.
    Filippi B; Biondi L; Filira F; Rocchi R; Bellini C; Sarto G
    Biopolymers; 1983 Jan; 22(1):575-8. PubMed ID: 6370327
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimum structure opioids-dipeptide and tripeptide analogs of the enkephalins.
    Vavrek RJ; Hsi LH; York EJ; Hall ME; Stewart JM
    Peptides; 1981; 2(3):303-8. PubMed ID: 6272246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity profiles of cyclic and linear enkephalin pseudopeptide analogs.
    Edwards JV; Spatola AF; Lemieux C; Schiller PW
    Biochem Biophys Res Commun; 1986 Apr; 136(2):730-6. PubMed ID: 3010995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of N alpha-, and C alpha-derivatives of (D)Ala2, Leu5-enkephalin.
    Filippi B; Biondi L; Filira F; Rocchi R
    Farmaco Sci; 1983 Oct; 38(10):713-24. PubMed ID: 6641923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mu rather than the delta subtype of opioid receptors appears to be involved in enkephalin-induced analgesia.
    Chaillet P; Coulaud A; Zajac JM; Fournie-Zaluski MC; Costentin J; Roques BP
    Eur J Pharmacol; 1984 May; 101(1-2):83-90. PubMed ID: 6086366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
    Suh HH; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine-enkephalin antagonism and endorphin potentiation of narcotic-induced analgesia.
    Chapman DB; Hu J; Way EL
    Eur J Pharmacol; 1980 Aug; 65(4):369-77. PubMed ID: 7190925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dalargin--an opioid-like peptide with peripheral action].
    Korobov NV
    Farmakol Toksikol; 1988; 51(4):35-8. PubMed ID: 3191970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-enkephalins--synthesis, activity on guinea-pig ileum, and analgesic effect.
    Lipkowski AW; Konecka AM; Sroczyńska I
    Peptides; 1982; 3(4):697-700. PubMed ID: 7134034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors.
    Kosterlitz HW; Lord JA; Paterson SJ; Waterfield AA
    Br J Pharmacol; 1980 Feb; 68(2):333-42. PubMed ID: 6101980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid activity of enkephalin analogues containing the kyotorphin-related structure in the N-terminus.
    Amano H; Morimoto Y; Kaneko S; Takagi H
    Neuropharmacology; 1984 Apr; 23(4):395-400. PubMed ID: 6328351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DSLET (D-ser2-leu5-enkephalin-Thr6) produces analgesia on the hot plate by mechanisms largely different from DAGO and morphine-like opioids.
    Belknap JK; Laursen SE
    Life Sci; 1987 Jul; 41(4):391-5. PubMed ID: 3298912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine enkephalin analogues containing a conformationally restrained N-terminal amino acid residue.
    Deeks T; Crooks PA; Waigh RD
    J Pharm Sci; 1984 Apr; 73(4):457-60. PubMed ID: 6726628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the structural parameters involved in the mu and delta opioid receptor discrimination of linear enkephalin-related peptides.
    Gacel G; Zajac JM; Delay-Goyet P; Daugé V; Roques BP
    J Med Chem; 1988 Feb; 31(2):374-83. PubMed ID: 2828622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.